Nobivac^® Tricat Trio, lyophilisate and solvent for suspension for injection for cats

Nobivac Tricat Trio is the UK’s leading core feline vaccine. It provides broad immunisation with live  attenuated feline calicivirus (FCV), feline herpes virus (FHV) and feline panleucopaenia virus (FPV). An extended minimum duration of immunity against panleucopaenia for up to 3 years from vaccination with Nobivac Tricat Trio means that on intervening years Nobivac Ducat, a bivalent vaccine against the two viral causes of Feline Upper Respiratory Track Disease, may be administered as the booster vaccine.

Presentation

Lyophilisate: Off-white lyophilisate with solvent for suspension for injection

Active ingredients

Live vaccine containing per dose of 1 ml reconstituted vaccine:

• live attenuated feline calicivirus, strain F9: ≥10^4.6 PFU¹;
• live attenuated feline herpes virus type 1, strain G2620A: ≥10^5.2 PFU¹;
• live attenuated feline panleucopenia virus, strain MW-1: ≥10^4.3 CCID₅₀²

¹PFU: Plaque-Forming Units
²CCID₅₀: Cell Culture Infective Dose 50%

Target species

Cats

Indications for use

Nobivac Tricat Trio is indicated for active immunisation of cats to reduce clinical signs caused by an infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV) and to prevent clinical signs, virus excretion and leucopaenia caused by feline panleucopaenia virus (FPV).

Packaging

A plastic box containing 10 or 50 single dose vials. The diluent may be packed together with the vaccine or separately.

Legal category

POM-V

Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.

Date of preparation: August 2025

Nobivac® Ducat contains live attenuated feline viral rhinotracheitis virus (strain G2620A) and feline calicivirus (strain F9). POM-V.